Last reviewed · How we verify
NCT05558852
Laparoscopic Central and Anterior Compartment Prolapse Surgery: A Meshless Sacrocolpopexy Technique
NA trial testing Laparoscopic Meshless Sacrocolpopexy Technique in Prolapse Uterovaginal in 25 participants. Status unknown.
15 October 2022
Quick facts
| Lead sponsor | Zeynep Kamil Maternity and Pediatric Research and Training Hospital |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 25 |
| Start date | 15 July 2022 |
| Primary completion | 15 October 2022 |
| Estimated completion | 15 April 2023 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Laparoscopic Meshless Sacrocolpopexy Technique
Conditions studied
- Prolapse Uterovaginal — all drugs for Prolapse Uterovaginal →
- Prolapse Bladder — all drugs for Prolapse Bladder →
- Laparoscopy — all drugs for Laparoscopy →
Sponsor
Zeynep Kamil Maternity and Pediatric Research and Training Hospital
Who can join
Adults 30 to 80, female only, with Prolapse Uterovaginal or Prolapse Bladder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Mesh is widely applied in the abdominal approach to pelvic organ prolapse surgery, and sacrocolpopexy-sacrohysteropexy is the gold standard application, particularly for central compartment abnormalities. There are numerous disadvantages associated with the use of mesh. In some studies, the rate of mesh complications (such as mesh erosion, contraction, response, and pain) can reach 20%. This surgical approach aims to provide laparoscopic repair of pelvic organ prolapse without the use of mesh, hence avoiding the difficulties associated with mesh.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05558852
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Prolapse Uterovaginal
Currently open trials in the same condition.
- NCT06404931 — Transvaginal Human Acellular Dermal Matrix for Prolapse Treatment · Phase 2 · recruiting
- NCT05836844 — Pragmatic Evaluation of Performance and Safety of the Anchorsure® Transvaginal Device for Surgical Treatment of Apical P · recruiting
Other Zeynep Kamil Maternity and Pediatric Research and Training Hospital trials
Trials by the same sponsor.
- NCT07312617 — Short-Term Outcomes of TOT, TVT, and Burch Surgery Assessed by Transperineal Ultrasound · NA · completed
- NCT05786352 — Outcomes of Enhanced Recovery After Cesarean (ERAC) Protocol · NA · unknown
- NCT05558046 — Predictive Value of Granulosa Cell DNA Damage in the Success of Assisted Reproductive Technique · unknown
- NCT04888091 — Comparison of the Effect of Cervical Mucus Cleaning Method Applied Before Embryo Transfer on Pregnancy Rates. · NA · completed
- NCT04891003 — The Identification of Optimal Ultrasonografic Tecniques for Determining the Location , Size and the Surgical Methods of · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05558852 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Zeynep Kamil Maternity and Pediatric Research and Training Hospital
- Last refreshed: 30 September 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05558852.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing